Impact of dupilumab for severe asthma on fatigue, quality of life, work productivity, and activity

Psoriatic Arthritis

The impact of psoriatic arthritis on quality of life: a systematic review

Ther Adv Musculoskelet Dis

James L, Hailey LH, Suribhatla R, McGagh D, Amarnani R, Bundy CE, Kirtley S, O'Sullivan D, Steinkoenig I, White JPE, Vivekanantham A, Coates LC

doi: 10.1177/1759720X241295920

Allergic Diseases

The psychological impact of vernal keratoconjunctivitis on families: An investigation on quality of life and psychological wellbeing

Pediatr Allergy Immunol

Natali L, Cardi V, Cavarzeran F, Leonardi A

doi: 10.1111/pai.70141

Further Publications Immunology

Effects of obesity on response to asthma biologic treatment: Longitudinal data from the United Kingdom Severe Asthma Registry

J Allergy Clin Immunol Pract

Gonem S, Redmond C, Busby J, Patel P, Jackson DJ, Mansur AH, Pfeffer P, Pantin T, Brown T, Patel M, Idris E, Subramanian D, Burhan H, Naveed S, Faruqi S, Rupani H, Vyas A, Masoli M, Chaudhuri R, Message S, Doherty M, Sammut D, Heaney LG, UK Severe Asthma Registry

doi: 10.1016/j.jaip.2025.07.041

Psoriasis

Sex Disparities of Health-related Quality of Life in Moderate to Severe Psoriasis: A Real-world Analysis from the Swiss Psoriasis Registry (SDNTT)

Acta Derm Venereol

Lichtenberger R, Maul LV, Birkenmaier I, Oyanguren I, Ak M, Heidemeyer K, Schlapbach C, Yawalkar N, Egeberg A, Thomsen SF, Thyssen JP, Sorbe C, Boehncke WH, Conrad C, Cozzio A, Kokolakis G, Micheroli R, Wu JJ, Kündig T, Navarini A, Maul JT

doi: 10.2340/actadv.v105.42296

Further Publications Immunology

Tezepelumab in real-life practice: Characteristics of patients commenced and efficacy in a nationwide, Danish cohort of patients with severe asthma

J Allergy Clin Immunol Pract

Baastrup Soendergaard M, Håkansson KEJ, Hansen S, Bjerrum AS, Schmid JM, Johansson SL, Rasmussen LM, Johnsen CR, Bonnesen B, Vijdea R, von Bülow A, Krogh NS, Hilberg O, Ulrik CS, Porsbjerg C

doi: 10.1016/j.jaip.2025.09.001

Allergic Diseases

The impact of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) on the health-related quality of life (HRQoL) experiences of adults with SJS/TEN: A mixed method systematic review

Br J Dermatol

O'Reilly P, Savarimalai R, Walsh S, Barry LA, Fortune DG, Bunker CB, Ryan S, Dodiuk-Gad R, Coffey A, Ingen-Housz-Oro S, Griffin L, Dore L, Delaunois I, Meskell P

doi: 10.1093/bjd/ljaf229

Psoriasis

A Phase 3, Randomized, Double-blind, Active-controlled Clinical Study to Compare BAT2206, a Ustekinumab Biosimilar, with Ustekinumab Reference Product in Patients with Moderate-to-severe Psoriasis: Treatment Period 2 Results (Post Week 28 to Week 52)

J Am Acad Dermatol

Man X, Zaharieva K, Pulka G, Żebrowska A, Deng Y, Mekokishvili L, Yang X, Qi Y, Gu C, Dong Q, Zheng M

doi: 10.1016/j.jaad.2025.08.005

Psoriatic Arthritis

Bimekizumab Improves Patient-Reported Outcomes and Work Productivity in Patients with Psoriatic Arthritis: 1-Year Results from Two Phase 3 Studies

J Rheumatol

Gladman DD, Mease PJ, Gossec L, Husni ME, Gottlieb AB, Ink B, Bajracharya R, Coarse J, Lyris N, Lambert J, Tillett W

doi: 10.3899/jrheum.2024-0923

Atopic Dermatitis

Onset and Long-Term Maintenance of Optimal Itch Response in Adult Patients with Moderate-to-Severe Atopic Dermatitis Treated with Dupilumab: Post Hoc Analysis from Two Phase 3 Trials

Adv Ther

Ständer S, Yosipovitch G, Simpson EL, Kim BS, Kabashima K, Thaçi D, Metz M, Chen Z, Hagen S, Bastian M

doi: 10.1007/s12325-025-03124-8

Related content